secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2023-11-15T23:59:59+00:00
Accession:  0001641489-23-000076
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics approves 1-for-40 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse split effective 4:01 PM ET on Nov 20, 2023; post-split trading begins Nov 21.
- Ratio 1-for-40 applies equally to Class A and Class B common stock; fractional shares rounded up.
- Split intended to regain compliance with Nasdaq $1.00 minimum bid price requirement.
- CUSIP for post-split Class A common stock: 91835204; proportionate ownership unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148923000076/0001641489-23-000076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148923000076/vtvt-20231114.htm
  HTML page:      https://secwatch.observer/filing/0001641489-23-000076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer